Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications

Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy because of their high immunomodulation ability, tropism towards inflamed and injured tissues, and their easy access and isolation. Currently, there are more than 1200 registered MSC clinical trials globally. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Wei-Zhan, Lin, Yi-Heng, Su, Long-Jyun, Wu, Meng-Shiue, Jeng, Han-Yin, Chang, Huan-Cheng, Huang, Yen-Hua, Ling, Thai-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043779/
https://www.ncbi.nlm.nih.gov/pubmed/33849537
http://dx.doi.org/10.1186/s12929-021-00725-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043779/
https://www.ncbi.nlm.nih.gov/pubmed/33849537
http://dx.doi.org/10.1186/s12929-021-00725-7

Ejemplares similares